The Effect of Long-Term HAART on the Incidence of Tuberculosis Among People Living with HIV in Addis Ababa, Ethiopia: A Matched Nested Case–Control Study

References

• Kwan CK, Ernst JD. HIV and tuberculosis: a deadly human syndemic. Clin Microbiol Rev. 2011;24(2):351–376. doi:10.1128/CMR.00042-1021482729
   PubMed Web of Science ®Google Scholar
• Meda ZC, Sombie I, Sanon OW, Mare D, Morisky DE, Chen YM. Risk factors of tuberculosis infection among HIV/AIDS patients in Burkina Faso. AIDS Res Hum Retroviruses. 2013;29(7):1045–1055. doi:10.1089/aid.2012.023923517547
   PubMed Web of Science ®Google Scholar
• World Health Organization. WHO Policy on Collaborative TB/HIV Activities, Guidelines for National Programs, and Other Stakeholders. Geneva, Switzerland: World Health Organization; 2012.
   Google Scholar
• World Health Organization. TB/HIV, HIV-Associated Tuberculosis Fact Sheet. Geneva, Switzerland: World Health Organization; 2018.
   Google Scholar
• World Health Organization. Global Tuberculosis Report. Geneva, Switzerland: World Health Organization; 2021.
   Google Scholar
• World Health Organization. Global Tuberculosis Report. Geneva, Switzerland: World Health Organization; 2020.
   Google Scholar
• Alene KA, Viney K, Moore HC, Wagaw M, Clements ACA. Spatial patterns of tuberculosis and HIV co-infection in Ethiopia. PLoS One. 2019;14(12):e0226127. doi:10.1371/journal.pone.022612731805149
   PubMed Web of Science ®Google Scholar
• Alemu YM, Awoke W, Wilder-Smith A. Determinants for tuberculosis in HIV-infected adults in Northwest Ethiopia: a multicentre case-control study. BMJ Open. 2016;6(4):e009058. doi:10.1136/bmjopen-2015-009058
   Web of Science ®Google Scholar
• Badri M, Wilson D, Wood R. Effect of highly active antiretroviral therapy on incidence of tuberculosis in South Africa: a cohort study. Lancet. 2002;359(9323):2059–2064. doi:10.1016/S0140-6736(02)08904-312086758
   PubMed Web of Science ®Google Scholar
• Cui Z, Lin M, Nie S, Lan R. Risk factors associated with Tuberculosis (TB) among people living with HIV/AIDS: a pair-matched case-control study in Guangxi, China. PLoS One. 2017;12(3):e0173976. doi:10.1371/journal.pone.017397628358846
   PubMed Web of Science ®Google Scholar
• Miranda A, Morgan M, Jamal L, et al. Impact of antiretroviral therapy on the incidence of tuberculosis: the Brazilian experience, 1995–2001. PLoS One. 2007;2(9):e826. doi:10.1371/journal.pone.000082617786198
   PubMed Web of Science ®Google Scholar
• Del Amo J, Moreno S, Bucher HC, et al. Impact of antiretroviral therapy on tuberculosis incidence among HIV-positive patients in high-income countries. Clin Infect Dis. 2012;54(9):1364–1372.22460971
   PubMed Web of Science ®Google Scholar
• Alemu A, Yesuf A, Zerihun B, Getu M, Worku T, Bitew ZW. Incidence and determinants of tuberculosis among HIV-positive individuals in Addis Ababa, Ethiopia: a retrospective cohort study. Int J Infect Dis. 2020;95:59–66. doi:10.1016/j.ijid.2020.02.05332126324
   PubMed Web of Science ®Google Scholar
• Taha M, Deribew A, Tessema F, Assegid S, Duchateau L, Colebunders R. Risk factors of active tuberculosis in people living with HIV/AIDS in southwest Ethiopia: a case-control study. Ethiop J Health Science. 2011;21(2):131–140.
   PubMedGoogle Scholar
• Yirdaw KD, Teklu AM, Mamuye AT, Zewdu S. Breakthrough tuberculosis disease among people with HIV - should we be worried? A retrospective longitudinal study. PLoS One. 2019;14(2):e0211688. doi:10.1371/journal.pone.021168830716126
   PubMed Web of Science ®Google Scholar
• Kibret KT, Yalew AW, Belaineh BG, Asres MM. Determinant factors associated with occurrence of tuberculosis among adult people living with HIV after antiretroviral treatment initiation in Addis Ababa, Ethiopia: a case-control study. PLoS One. 2013;8(5):e64488. doi:10.1371/journal.pone.006448823762214
   PubMed Web of Science ®Google Scholar
• Azanaw MM, Derseh NM, Yetemegn GS, Angaw DA. Incidence and predictors of tuberculosis among HIV patients after initiation of ART treatment in Ethiopia: a systematic review and meta-analysis. Res Sq. 2020. doi:10.21203/rs.2.19054/v1
   Google Scholar
• Mitku AA, Dessie ZG, Muluneh EK, Workie DL. Prevalence and associated factors of TB/HIV co-infection among HIV infected patients in Amhara region, Ethiopia. Afr Health Sci. 2016;16(2):588–595. doi:10.4314/ahs.v16i2.2927605976
   PubMed Web of Science ®Google Scholar
• Aemro A, Jember A, Anlay DZ. Incidence and predictors of tuberculosis occurrence among adults on antiretroviral therapy at Debre Markos referral hospital, Northwest Ethiopia: a retrospective follow-up study. BMC Infect Dis. 2020;20(1):245. doi:10.1186/s12879-020-04959-y32216747
   PubMed Web of Science ®Google Scholar
• Girardi E, Sabin CA, Monforte AA, et al. Incidence of tuberculosis among HIV-infected patients receiving highly active antiretroviral therapy in Europe and North America. Clin Infect Dis. 2005;41:1772–1782.16288403
   PubMed Web of Science ®Google Scholar
• Alene KA, Nega A, Taye BW. Incidence and predictors of tuberculosis among adult people living with human immunodeficiency virus at the University of Gondar Referral Hospital, Northwest Ethiopia. BMC Infect Dis. 2013;13(1):292. doi:10.1186/1471-2334-13-29223806088
   PubMed Web of Science ®Google Scholar
• Kassa A, Teka A, Shewaamare A, Jerene D. Incidence of tuberculosis and early mortality in a large cohort of HIV infected patients receiving antiretroviral therapy in a tertiary hospital in Addis Ababa, Ethiopia. Trans R Soc Trop Med Hyg. 2012;106(6):363–370. doi:10.1016/j.trstmh.2012.03.00222521216
   PubMed Web of Science ®Google Scholar
• Ahmed A, Mekonnen D, Shiferaw AM, Belayneh F, Yenit MK. Incidence and determinants of tuberculosis infection among adult patients with HIV attending HIV care in north-east Ethiopia: a retrospective cohort study. BMJ Open. 2018;8(2):e016961. doi:10.1136/bmjopen-2017-016961
   PubMed Web of Science ®Google Scholar
• Federal Democratic Republic of Ethiopia Ministry of Health. National comprehensive tuberculosis, leprosy and TB/HIV training manual for health care workers; 2016:26.
   Google Scholar
• Seyler C, Toure S, Messou E, Bonard D, Gabillard D, Anglaret X. Risk factors for active tuberculosis after antiretroviral treatment initiation in Abidjan. Am J Respir Crit Care Med. 2005;172(1):123–127. doi:10.1164/rccm.200410-1342OC15805184
   PubMed Web of Science ®Google Scholar
• Nugus GG, Irena ME. Determinants of active tuberculosis occurrences after ART initiation among adult HIV-positive clients in West Showa Zone Public Hospitals, Ethiopia: a case-control study. Adv Public Health. 2020;2020:1–8. doi:10.1155/2020/8237928
   Google Scholar
• Unis G, Ribeiro AW, Esteves LS, et al. Tuberculosis recurrence in a high incidence setting for HIV and tuberculosis in Brazil. BMC Infect Dis. 2014;14(1):548. doi:10.1186/s12879-014-0548-625338623
   PubMed Web of Science ®Google Scholar
• Brinkhof MWG, Egger E, Boulle A, et al. Tuberculosis after initiation of antiretroviral therapy in low-income and high-income countries. Clin Infect Dis. 2007;45(11):1518–1521.17990236
   PubMed Web of Science ®Google Scholar
• Tiruneh G, Getahun A, Adeba E. Assessing the Impact of Isoniazid Preventive Therapy (IPT) on tuberculosis incidence and predictors of tuberculosis among adult patients enrolled on ART in Nekemte Town, Western Ethiopia: a retrospective cohort study. Interdiscip Perspect Infect Dis. 2019;2019:1413427. doi:10.1155/2019/141342731186628
   PubMedGoogle Scholar
• Gunda DW, Maganga SC, Nkandala I, et al. Prevalence and risk factors of active TB among adult HIV patients receiving ART in Northwestern Tanzania: a retrospective cohort study. Can J Infect Dis Med Microbiol. 2018;2018:1346104. doi:10.1155/2018/134610430073038
   PubMed Web of Science ®Google Scholar
• Kigozi IM, Dobkin LM, Martin JN, et al. Late-disease stage at presentation to an HIV clinic in the era of free antiretroviral therapy in Sub-Saharan Africa. J Acquir Immune Defic Syndr. 2009;52(2):280–289. doi:10.1097/QAI.0b013e3181ab6eab19521248
   PubMed Web of Science ®Google Scholar
• Hu X, Liang B, Zhou C, et al. HIV late presentation and advanced HIV disease among patients with newly diagnosed HIV/AIDS in Southwestern China: a large-scale cross-sectional study. AIDS Res Ther. 2019;16(1):6. doi:10.1186/s12981-019-0221-730876476
   PubMed Web of Science ®Google Scholar
• Dravid A, Natarajan K, Medisetty M, et al. Incidence of tuberculosis among HIV infected individuals on long term antiretroviral therapy in private healthcare sector in Pune, Western India. BMC Infect Dis. 2019;19(1):714. doi:10.1186/s12879-019-4361-031409289
   PubMed Web of Science ®Google Scholar
• World Health Organization. Implementing the WHO Stop TB Strategy. Geneva, Switzerland: World Health Organization; 2008.
   Google Scholar
• Pettit AC, Jenkins CA, Stinnette SE, et al. Tuberculosis risk before and after highly active antiretroviral therapy initiation: does HAART increase the short-term TB risk in a low incidence TB setting? J Acquir Immune Defic Syndr. 2011;57(4):305–310. doi:10.1097/QAI.0b013e3182182e2d21423024
   PubMed Web of Science ®Google Scholar
• Van Rie A, Westreich D, Sanne I. Tuberculosis in patients receiving antiretroviral treatment: incidence, risk factors, and prevention strategies. J Acquir Immune Defic Syndr. 2011;56(4):349–355. doi:10.1097/QAI.0b013e3181f9fb3920926954
   PubMed Web of Science ®Google Scholar
• Ali K, Klotz SA. The immune reconstitution inflammatory syndrome with tuberculosis: a common problem in Ethiopian HIV-infected patients beginning antiretroviral therapy. J Int Assoc Physicians AIDS Care. 2012;11(3):198–202. doi:10.1177/1545109711402212
   Google Scholar